药品名称NAPHCON-A
申请号020226产品号001
活性成分NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE市场状态非处方药
剂型或给药途径SOLUTION/DROPS;OPHTHALMIC规格0.025%;0.3%
治疗等效代码参比药物
批准日期1994/06/08申请机构ALCON LABORATORIES INC
化学类型New combination审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020226024AP2015/07/31Manufacturing Change or Addition
020226022AP2014/06/23Manufacturing Change or Addition
020226018AP2002/12/04Control Supplement
020226017AP2001/03/16Control Supplement
020226016AP2000/09/22Manufacturing Change or Addition
020226015AP2000/03/17Package Change
020226014AP2000/01/21Manufacturing Change or Addition
020226013AP1999/11/19Manufacturing Change or Addition
020226012AP1999/10/04Control Supplement
020226011AP1999/06/14Manufacturing Change or Addition
020226010AP1999/12/16Control Supplement
020226009AP1998/08/20Control Supplement
020226008AP1997/12/23Manufacturing Change or Addition
020226007AP1996/09/26Labeling Revision
020226006AP1996/04/16Control Supplement
020226005AP1996/07/30Labeling Revision
020226004AP1995/11/01Control Supplement
020226003AP1995/11/01Control Supplement
020226002AP1995/02/23Labeling Revision
020226001AP1994/10/04Labeling Revision
020226000AP1994/06/08Approval